These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Continuity of cytokine activation in patients with familial Mediterranean fever. Bagci S; Toy B; Tuzun A; Ates Y; Aslan M; Inal A; Gulsen M; Karaeren N; Dagalp K Clin Rheumatol; 2004 Aug; 23(4):333-7. PubMed ID: 15293095 [TBL] [Abstract][Full Text] [Related]
4. Does immune activation continue during an attack-free period in familial Mediterranean fever? Musabak U; Sengul A; Oktenli C; Pay S; Yesilova Z; Kenar L; Sanisoglu SY; Inal A; Tuzun A; Erdil A; Bagci S Clin Exp Immunol; 2004 Dec; 138(3):526-33. PubMed ID: 15544632 [TBL] [Abstract][Full Text] [Related]
5. Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever (FMF) patients and their first degree relatives. Oktem S; Yavuzsen TU; Sengül B; Akhunlar H; Akar S; Tunca M Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S34-6. PubMed ID: 15515781 [TBL] [Abstract][Full Text] [Related]
6. Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever. Kisacik B; Akdogan A; Yilmaz G; Karadag O; Yilmaz FM; Koklu S; Yuksel O; Ertenli AI; Kiraz S Eur J Intern Med; 2009 Jan; 20(1):44-7. PubMed ID: 19237091 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period. Salimov A; Akyol U; Cildir B; Batu ED; Ozen S Int J Pediatr Otorhinolaryngol; 2019 Apr; 119():185-192. PubMed ID: 30743166 [TBL] [Abstract][Full Text] [Related]
13. Role of serum calprotectin in identifying familial Mediterranean fever attacks. Polat MG; Omma A; Gokcen N; Kilinckaya MF; Ozkan Karaahmetoglu S Ir J Med Sci; 2024 Aug; 193(4):1901-1909. PubMed ID: 38478181 [TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis. Matsumoto T; Iwasaki K Ann Rheum Dis; 1993 Dec; 52(12):876-80. PubMed ID: 8311539 [TBL] [Abstract][Full Text] [Related]
15. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever? Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601 [TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections. Çakan M; Aktay Ayaz N; Keskindemirci G; Karadağ ŞG; Tanatar A; Sönmez HE Clin Rheumatol; 2020 Jan; 39(1):249-253. PubMed ID: 31485845 [TBL] [Abstract][Full Text] [Related]
17. The significance of urinary beta-2 microglobulin level for differential diagnosis of familial Mediterranean fever and acute appendicitis. Ugan Y; Korkmaz H; Dogru A; Koca YS; Balkarlı A; Aylak F; Tunc SE Clin Rheumatol; 2016 Jul; 35(7):1669-72. PubMed ID: 26873102 [TBL] [Abstract][Full Text] [Related]
18. Plasma nitric oxide level in familial Mediterranean fever and its modulations by Immuno-Guard. Panossian A; Hambartsumyan M; Panosyan L; Abrahamyan H; Mamikonyan G; Gabrielyan E; Amaryan G; Astvatsatryan V; Wikman G Nitric Oxide; 2003 Sep; 9(2):103-10. PubMed ID: 14623176 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of S100A12 protein levels in children with familial Mediterranean fever. Türkmenoğlu Y; Güney E; Bezen D; İrdem A; Ertürk B; Dursun H Turk J Med Sci; 2021 Jun; 51(3):1396-1405. PubMed ID: 33576586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]